testavan 20 mg/g transdermales gel
the simple pharma company limited - testosteron -
skinoren 15% - gel
leo pharma a/s - azelainsÄure - azelainsäure
finacea 150 mg/g gel
leo pharma a/s - azelainsÄure - azelainsäure
dalacin topical 1 % gel
pfizer - clindamycin-phosphat - gel - 1 % - clindamycin-phosphat 11.88 mg/g - clindamycin
andropecia biorga 1 mg filmtablette
bailleul (suisse) sa - finasteridum - filmtablette - finasteridum 1 mg, excipiens pro compresso obducto. - androgenetische alopezie - synthetika
xtandi
astellas pharma europe b.v. - enzalutamid - prostata-neoplasmen - endokrine therapie - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.
bicalutamid teva 150 mg filmtabletten
teva pharma bv - bicalutamid - bicalutamid
bicalutamid sandoz 150 mg - filmtabletten
sandoz gmbh - bicalutamid - bicalutamid
bicalutamid hexal 150 mg - filmtabletten
hexal pharma gmbh - bicalutamid - bicalutamid
bicalutamid 1a pharma 150 mg - filmtabletten
1a pharma gmbh - bicalutamid - bicalutamid